VISTA PHARMACEUTICALS LTD.VISTA PHARMACEUTICALS LTD.VISTA PHARMACEUTICALS LTD.

VISTA PHARMACEUTICALS LTD.

No trades
See on Supercharts
Market capitalization
‪496.72 M‬INR
−2.06INR
‪−56.62 M‬INR
‪10.04 M‬INR
Beta (1Y)
0.09

About VISTA PHARMACEUTICALS LTD.

CEO
Murali Meraga
Headquarters
Hyderabad
Founded
1991
ISIN
INE427C01021
FIGI
BBG000DXRL88
Vista Pharmaceuticals Ltd. engages in the manufacture and market of pharmaceutical products. It offers over the counter and prescription generic drug products consisting of tablets, capsules, and liquids covering different therapeutic categories. The company was founded by Dhananjaya Alli on January 25, 1991 and is headquartered in Hyderabad, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VISTAPH is 14.00 INR — it has increased by 3.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange VISTA PHARMACEUTICALS LTD. stocks are traded under the ticker VISTAPH.
VISTAPH stock is 4.81% volatile and has beta coefficient of 0.09. Check out the list of the most volatile stocks — is VISTA PHARMACEUTICALS LTD. there?
Yes, you can track VISTA PHARMACEUTICALS LTD. financials in yearly and quarterly reports right on TradingView.
VISTAPH stock has fallen by 4.76% compared to the previous week, the month change is a 10.50% rise, over the last year VISTA PHARMACEUTICALS LTD. has showed a 45.08% increase.
VISTAPH net income for the last quarter is ‪−16.29 M‬ INR, while the quarter before that showed ‪−20.19 M‬ INR of net income which accounts for 19.33% change. Track more VISTA PHARMACEUTICALS LTD. financial stats to get the full picture.
Today VISTA PHARMACEUTICALS LTD. has the market capitalization of ‪496.72 M‬, it has increased by 21.12% over the last week.
No, VISTAPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VISTAPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VISTA PHARMACEUTICALS LTD. stock right from TradingView charts — choose your broker and connect to your account.
VISTAPH reached its all-time high on Mar 1, 2018 with the price of 56.15 INR, and its all-time low was 1.22 INR and was reached on Aug 12, 2013.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VISTA PHARMACEUTICALS LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VISTA PHARMACEUTICALS LTD. stock shows the buy signal. See more of VISTA PHARMACEUTICALS LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VISTA PHARMACEUTICALS LTD. EBITDA is ‪−49.52 M‬ INR, and current EBITDA margin is −399.67%. See more stats in VISTA PHARMACEUTICALS LTD. financial statements.